Ignite Creation Date:
2025-12-25 @ 4:24 AM
Ignite Modification Date:
2026-05-01 @ 5:54 AM
Study NCT ID:
NCT04567420
Status:
RECRUITING
Last Update Posted:
2025-10-16
First Post:
2020-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Sponsor:
Criterium, Inc.
Organization: